Growth Metrics

Sunshine Biopharma (SBFM) Gains from Investment Securities (2016 - 2024)

Sunshine Biopharma's Gains from Investment Securities history spans 4 years, with the latest figure at -$373529.0 for Q4 2024.

  • For Q4 2024, Gains from Investment Securities changed N/A year-over-year to -$373529.0; the TTM value through Sep 2025 reached -$373529.0, down 139.07%, while the annual FY2024 figure was $582483.0, N/A changed from the prior year.
  • Gains from Investment Securities reached -$373529.0 in Q4 2024 per SBFM's latest filing, down from $956012.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $956012.0 in Q1 2024 to a low of -$373529.0 in Q4 2024.